Cara Therapeutics

+$0.23 (+2.87%) Today

+$0.26 (+3.16%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARA and other ETFs, options, and stocks.

About CARA

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain.

CEO

Christopher Posner

Employees

Headquarters

Stamford, Connecticut

Founded

2004

CARA Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

556.45K

High today

$8.29

Low today

$7.89

Open price

$8.16

Volume

281.94K

52 Week high

$18.93

52 Week low

$7.40

CARA News

Simply Wall StMay 23

What Type Of Shareholders Own The Most Number of Cara Therapeutics, Inc. Shares? - Yahoo Finance

A look at the shareholders of Cara Therapeutics, Inc. (NASDAQ:CARA) can tell us which group is most powerful. Institutions will often hold stock in bigger compa

Analyst ratings

Buy

87.5%

Hold

12.5%

Sell

CARA Earnings

-$0.63

$0.11

$0.85

$1.59

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 8, After Hours

Why Robinhood?

What Type Of Shareholders Own The Most Number of Cara Therapeutics, Inc. Shares? - Yahoo Finance

88%